J. A. Staessen, J.-G. Wang and L. Thijs, “Cardiovascular Prevention and Blood Pressure Reduction: A Quantitative Overview Updated until March 2003,” Journal of Human Hypertension, Vol. 21, No. 6, 2003, pp. 1055-1076.
 M. K. Patricia, W. Megan, R. Kristi, K. W. Paul and H. Jiang, “Worldwide Prevalence of Hypertension: A Systematic Review,” Journal of Hypertension, Vol. 22, No. 1, 2004, pp. 11-19.
 S. Krisela, A. G. Thomas, B. Debbie, L. Ria and F. Jean, “Hypertension in South African Adults: Results from the Demographic and Health Survey, 1998,” Journal of Hypertension, Vol. 19, No. 10, 2001, pp. 1717-1725.
 J. Wang, X. Ning, L. Yang, H. Lu, J. Tu and W. Jin, “Trends of Hypertension Prevalence, Awareness, Treatment and Control in Rural Areas of Northern China during 1991-2011,” Journal of Human Hypertension, 2013.
 Y. Gao, G. Chen, H. Tian, L. Lin, J. Lu, J. P. Weng, et al., “Prevalence of Hypertension in China: A Cross-Sectional Study,” Plos One, Vol. 8, No. 6, 2013, p. e65938.
 T. M. Spruill, “Chronic Psychosocial Stress and Hypertension,” Current Hypertension Reports, Vol. 12, No. 1, 2010, pp. 10-16.
 R. M. Osti, G. Trombini and B. Magnani, “Stress and Distress in Essential Hypertension,” Psychotherapy and Psychosomatics, Vol. 33, No. 4, 1980, pp. 193-197.
 T. Okura, M. Jotoku, J. Irita, D. Enomoto, T. Nagao, V. R. Desilva, et al., “Association between Cystatin C and Inflammation in Patients with Essential Hypertension,” Clinical and Experimental Nephrology, Vol. 14, No. 6, 2010, pp. 584-588.
 B. Chamarthi, G. H. Williams, V. Ricchiuti, N. Srikumar, P. N. Hopkins, J. M. Luther, et al., “Inflammation and Hypertension: The Interplay of Interleukin-6, Dietary Sodium, and the Renin-Angiotensin System in Humans,” American Journal of Hypertension, Vol. 24, No. 10, 2011, pp. 1143-1148. http://dx.doi.org/10.1038/ajh.2011.113
 M. Hamer and A. Stepton, “Association between Physical Fitness, Parasympathetic Control and Proinflammatory Responses to Mental Stress,” Psychosomatic Medicine, Vol. 69, No. 7, 2007, pp. 660-666.
 S. C. Harwani, M. W. Chapleau, K. L. Legge, Z. K. Ballas and F. M. Abboud, “Neurohormonal Modulation of the Innate Immune System Is Proinflammatory in the Prehypertensive Spontaneously Hypertensive Rat, a Genetic Model of Essential Hypertension,” Circulation Research, Vol. 111, No. 9, 2012, pp. 1190-1197.
 S. Sriramula, J. P. Cardinale and J. Francis, “Inhibition of TNF in the Brain Reverses Alterations in RAS Components and Attenuates Angiotensin II-Induced Hypertension,” Plos One, Vol. 8, No. 5, 2013, p. e63847.
 W. Rief and M. Fichter, “The Symptom Check List SCL-90-Rand and Its Ability to Discriminate between Dysthymia, Anxiety Disorders, and Anorexia Nervosa,” Psychopathology, Vol. 25, No. 3, 1992, pp. 128-138.
 W. W. Ji, J. Zhou, H. X. Li, D. Bai and H. F. Yang, “Psycho-Behavioral Status and Influencing Factors in Hui and Han Chinese Patients with Hypertension,” Occupational and Environmental Medicine, Vol. 29, No. 2, 2012, pp. 104-106.
 A. Grimsrud, D. J. Stein, S. Seedat, D. Williams and L. Myer, “The Association between Hypertension and Depression and Anxiety Disorders: Results from a NationallyRepresentative Sample of South African Adults,” Plos One, Vol. 4, No. 5, 2009, p. e5552.
 J. E. Dimsdale, “Psychological Stress and Cardiovascular Disease,” Journal of the American College of Cardiology, Vol. 51, No. 13, 2008, pp. 1237-1246.
 M. Domanski and M. Proschan, “The Metabolic Syndrome,” Journal of the American College of Cardiology, Vol. 43, 2004, pp. 138-139.
 S. S. David, B. C. Janet, A. J. Sherman, L. K. Nora, R. B. Steven, M. G. Joanne, et al., “Social Support, Stress and Blood Pressure in Black Adults,” Epidemiology, Vol. 8, No. 5, 1997, pp. 482-497.
 J. E. Williams, F. J. Nieto, C. P. Sanford and H. A. Tyroler, “Effects of an Angry Temperament on Coronary Heart Disease Risk: The Atherosclerosis Risk in Communities Study,” American Journal of Epidemiology, Vol. 154, No. 3, 2001, pp. 230-235.
 J. P. Granger, B. T. Alexander, M. T. Llinas, W. A. Bennett and R. A. Khalil, “Pathophysiology of Hypertension during Preeclampsia Linking Placental Ischemia with Endothelial Dysfunction,” Hypertension, Vol. 38, No. 3, 2001, pp. 718-722.
 L. E. Bautista, L. M. Vera, I. A. Arenas and G. Gamarra, “Independent Association between Inflammatory Markers (C-Reactive Protein, Interleukin-6, and TNF-Alpha) and Essential Hypertension,” Journal of Human Hypertension, Vol. 19, No. 2, 2004, pp. 149-157.
 J. L. Cheng, A. L. Wang and J. Wan, “Association between the M235T Polymorphism of the AGT Gene and Cytokines in Patients with Hypertension,” Experimental and Therapeutic Medicine, Vol. 3, No. 3, 2012, pp. 509-512.
 K. Matsubara, E. Abe, H. Ochi, Y. Kusanagi and M. Ito, “Changes in Concentrations of Tumor Necrosis Factor Alpha and Adhesion Molecules in Normal Pregnant Women and Those with Pregnancy-Induced Hypertension,” Journal of Obstetrics and Gynaecology Research, Vol. 29, No. 6, 2003, pp. 422-442.